Research Study Summary
The Parkinson's Progression Markers Initiative (PPMI)
You are being invited to take part in this study because you are thought to have early Parkinson disease (PD). In this research study we will collect clinical information, samples of blood, DNA, urine, cerebral spinal fluid, and brain images from subjects with PD and from subjects without PD. This information will be used to help develop biomarkers for PD. Biomarkers are measures that tell something about PD. We are working on biomarkers in PD because they may help to understand how the disease changes over time. Having good biomarkers for PD may also be useful in developing new treatments and may help to improve clinical care in the future. In this study we will test biomarkers that may be related to the way PD changes over time. We will store information about all the tests and samples of the different fluids, such as blood, urine, spinal fluid, and DNA, for future testing.
Patient Inclusion Criteria:
- Must be age 30 or older.
- Must have a diagnosis of Parkinson's disease for 2 years or less at time of screening.
- Subject can not be taking any medications for Parkinson's disease.
Patient Exclusion Criteria: Please contact BSHRI to get details
To Learn more
Date Last Changed:
July 19, 2013
Clinical Trial Snapshot
- Both Male and Female
- 30 and up
- Overall Status
- Facility Type
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.